Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glaucoma: full-pipeline trial registry
39 of 94 indexed Glaucoma trials are currently recruiting.
Corpus placement: #143 of 28,707 conditions by registered trial count.
94 US clinical trials · 39 currently recruiting · #143 of 28,707 conditions by registered trial count
Glaucoma: 94 US clinical trials tracked, 39 recruiting.
Glaucoma is the subject of 94 registered US clinical trials on ClinicalTrials.gov, 39 of them currently open to new participants. 16 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is Stanford University, running 8 of these trials.
Enrollment posture brief
Registry condition glaucoma
OPEN 39 | RECR 41% | LATE 16 | EARLY 21 | RANK #143 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Post Traumatic Stress Disorder (42% recruiting · 265 trials)
Glaucoma lists 39 open slots (41% of 94 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glaucoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glaucoma recruits in line with its size-band peers.
39 of 94 indexed trials (41.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Glaucoma trials is spread across many organizations.
Stanford University accounts for 8 of 94 trials (8.5%). 56 distinct sponsors appear on at least one study for this condition label.
-
Typical Glaucoma enrolment sits around 92 participants.
Median target enrolment is 92 among the 93 trials that report a genuine target (sentinel values excluded). 48 of those (51.6%) plan for fewer than 100 participants.
-
Glaucoma research is mostly interventional.
71 interventional and 23 observational studies make up this index (75.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
94 total, page 1 of 2
Village-Integrated Eye Worker Trial II
University of California, San Francisco
NCT03752840
Novel Glaucoma Diagnostics
Wills Eye
NCT00286637
The Glaucoma and Retinopathy Screening Study
Massachusetts Eye and Ear Infirmary
NCT06882356
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
University of Alabama at Birmingham
NCT06629649
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
University of Michigan
NCT06934577
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
NCT07075718
Stem Cell Ophthalmology Treatment Study II
MD Stem Cells
NCT03011541
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
SpyGlass Pharma
NCT07218783
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
SpyGlass Pharma
NCT07218796
Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
State University of New York at Buffalo
NCT05523622
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
Glaukos Corporation
NCT06057051
A Trial of Hydrus Microstent Versus Goniotomy
Massachusetts Eye and Ear Infirmary
NCT06289491
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Bausch & Lomb Incorporated
NCT07168902
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
University of Pennsylvania
NCT05924477
Automated Applanation Tonometry - Updated
Duke University
NCT07298356
Data Gathering for A10900
Optos
NCT07149740
Functional and Structural Imaging for Glaucoma
Oregon Health and Science University
NCT01957267
To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.
The New York Eye & Ear Infirmary
NCT07425496
Ocular Blood Flow Imaging for Glaucoma Assessment
University of Maryland, Baltimore
NCT05726058
Pilocarpine Use After Kahook Goniotomy
Montefiore Medical Center
NCT03933631
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
Smartlens
NCT06689696
Retinal Blood Flow and Autoregulation
University of Maryland, Baltimore
NCT05344274
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
University of California, Los Angeles
NCT04354545
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
Brian Shafer
NCT07076303
Hyperbaric Oxygen Therapy for Optic Neuropathies
Stanford University
NCT06128720
Perimetric Testing With Virtual Reality
Envision Health Technologies
NCT06549010
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
University of Maryland, Baltimore
NCT06993597
Community Based Treatment for (ComBaT) Glaucoma
University of Michigan
NCT06124521
Topical Insulin for Glaucoma
Stanford University
NCT05206877
Tolerability of an Anesthesia-free Tonometer Tip
Duke University
NCT06585423
Glaucoma Laser Assessment of Stability and Sustainability
Twin Cities Eye Consultants
NCT06963684
Eye Pressure Lowering Surgery
Oregon Health and Science University
NCT01931904
Electrical Stimulation for the Treatment of Glaucoma
Stanford University
NCT05626491
Electrical Stimulation for the Treatment of Optic Neuropathies
Stanford University
NCT05626426
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
Johns Hopkins University
NCT06971588
Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
NCT07209410
Optimize Pediatric OCT Imaging
Duke University
NCT06139523
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Stanford University
NCT06685211
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
University of Miami
NCT07217678
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
iSTAR Medical
NCT05024695
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
Columbia University
NCT04271709
iStent Inject New Enrollment Post-Approval Study
Glaukos Corporation
NCT04624698
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
Interstat
NCT07216677
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution
SpyGlass Pharma
NCT06120842
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
Laboratoires Thea
NCT05389267
Anterior Segment Optical Coherence Tomography Microstent Positioning
University of Utah
NCT06666751
Visual Field Analysis With Artificial Intelligence
Sight Intelligence Engineering Corporation
NCT06920290
Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
Stanford University
NCT02862938
Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
Stanford University
NCT04577300
A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery
Sanjay Asrani
NCT04918121
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 10 |
| Phase 3 | 5 |
| Phase 4 | 11 |
Top Sponsors
Named interventions
Most-linked intervention names on Glaucoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glaucoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glaucoma page
94 registered trials, 39 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 39 Glaucoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Stanford University sponsors the most Glaucoma trials on record, review their full trial history before evaluating a specific study. See Stanford University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glaucoma condition card totals 94 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.